Gregory Austin Ciongoli - 11 Aug 2025 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
ZYME
Transactions as of
11 Aug 2025
Net transactions value
+$4,988,300
Form type
4
Filing time
12 Aug 2025, 20:30:06 UTC
Previous filing
12 Aug 2025
Next filing
12 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ciongoli Gregory Austin Director C/O ZYMEWORKS INC., 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN /s/ Daniel Dex, Attorney-in-Fact 12 Aug 2025 0002023732

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYME Common Stock Award $4,988,300 +415,000 +565% $12.02 488,500 12 Aug 2025 Direct
holding ZYME Common Stock 5,000 11 Aug 2025 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +62,000 $0.000000 62,000 11 Aug 2025 Common Stock 62,000 $12.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held by 4 Arrows Holdings, LLC, for which the reporting person is the manager. The reporting person exercises sole voting and dispositive power over these shares and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Stock options vest in 36 equal monthly installments starting one month after grant date of August 11, 2025.